Regulatory process regulations

CFTR has a single-channel conductance of about 8 pS. It is present in the apical membranes of many epithelia. Its mutation leads to the potentially lethal disease cystic fibrosis. In addition to acting as a chloride channel, CFTR is also thought to regulate, e.g., the epithelial sodium channel ENaC, a molecularly unknown outwardly-rectifying chloride channel, and possibly also potassium channels and water channels. Some of these potential regulatory processes, however, are controversial. CFTR also acts as a receptor for bacteria. 

The Federal Drug Administration (FDA) describes the biopharmaceutical industries as self-regulated, retaining for itself the responsibility of assuring and checking on that self-regulatory process. Not surprisingly, then. 

For a skeletal element to respond to its mechanical environment, the cells in the tissue must regulate their environment in response to the mechanical stimuli they receive. The regulatory process can be thought of as a feedback loop (Figure 7.5) in which the osteocyte senses the stimulus and... 

Standards and guidelines should be established in written form for all dmg regulatory functions. These tools should then be used to guide regulation practice, as well as being made publicly available in order to ensure the transparency of the dmg regulatory process. 

Besides stiuctural constraints, e.g. human and financial resources, the way in which DRA employees perceive their jobs and how they perform are key factors in drug regulation performance. A clear sense of mission on the part of employees is important if regulatory processes are to be pursued consistently. 

A clear sense of the mission of the regulatory authority is important in motivating DRA staff to pursue regulatory processes in order to achieve dmg regulation. Governments should state clearly the mission and objectives of dmg regulation, so that the attainment of the intended objectives can be easily assessed. 

This presentation addresses tissue engineering and how it relates to biomaterials and medical devices. Consideration is given to risk analysis and risk management in tissue engineering, and current proposals are discussed for an approach to the regulation of tissue engineering products and regulatory processes in the European Union. EUROPEAN COMMUNITY EUROPEAN UNION UK WESTERN EUROPE... 

Counter-regulation in acute hypotension due to vasodilators (B). Increased sympathetic drive raises heart rate (reflex tachycardia) and cardiac output and thus helps to elevate blood pressure. Patients experience palpitations. Activation of the renin-angioten-sin-aidosterone (RAA) system serves to increase blood volume, hence cardiac output. Fluid retention leads to an increase in body weight and, possibly, edemas. These counter-regulatory processes are susceptible to pharmacological inhibition ( 3-blockers, ACE inhibitors, ATI-antagonists, diuretics). 

In summary, due fo fhe large panel of cell cycle regulatory proteins regulated by HDACs at the level of either their expression or activity, the antiproliferative effect of HDAC inhibitors cannot be linked to a single mechanism of action. The relative importance of the different proteins affected by HDACs varies between tumors. In Fig. 2, a visual overview of the role of HDACs in various hallmark processes in the development of cancer is shown. 

Jaffe, G. (2004b). Regulating transgenic crops a comparative analysis of different regulatory processes. Transgenic Res. 13 5-19. 

Of particular interest for regulatory processes are mechanisms by which the activity of growth regulating proteins and central transcription factors are controlled via ubiquiti-nylation. Often the cell uses signal pathway mediated protein phosphorylation in order to induce the regulated degradation of a signal protein. Examples are the G1 cychns, the tumor suppressor p53 and the inhibitor IxB. 

---